FMT trial for MDRO decolonization, Atlanta, USA
95 samples from adult and elderly participants in Atlanta, GA, USA, from a randomized clinical trial of fecal microbiota transplant (FMT) for eradication of intestinal multi-drug resistant organism colonization after infection. machine-written summary
95 samples · 155 runs · US · Adult · 2022 · 4.07 Gbp / sample
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 1,229 sample values (age, country, health condition, health condition detail, intervention, intervention detail, latitude, location locality) |
| ○ Abstract / description | read; no usable statement |
| – Full text | no open-access full text linked |
| – Supplementary tables | no supplementary tables available (or none open access) |
| – External resources | not covered by the external resources we ingest |
| – User contribution | nothing uploaded yet |
| – Human verified | not yet checked by a person · I checked this project — verify it |
intervention · arms resolved
10 people have samples in more than one arm.
Faecal microbiota transplantation design randomized_controlled_trial · population transplant_or_immunocompromised · FMT vs delayed FMT for MDRO decolonization in transplant recipients
“randomized 1:1 to FMT or an observation period” — abstract:37910603 (study level; per-sample arms are in the intervention column below)
longitudinal — not resolvedFMT donor → recipient
12 of 12 people sampled more than once (95 samples; median 6, up to 14 per person). Schedule stated by the source: “Samples collected at Day 1, 2, 15, and 36 within each cycle (C0, C1, C2), plus screening visits S1-S3, per subject.”.
single stool donor SD01; 6 donor dose lots sequenced and linked to 12 recipient FMT courses via fmt_dose (13 donor->recipient links).
donorrecipient · circles are people (pale = no sequenced sample), arrows run donor → recipient and parent → child, curved lines join twins, partners and siblings, squares are shared settings or families without recorded roles. Shown: 1 linked group from explicit relations. 12 people in the project overall.
Genera, mean relative abundance over 90 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 95 | 100% | ||||
| country | 95 | 100% | 95 | |||
| health_condition | 89 | 94% | 89 | |||
| subject_id | 95 | 100% | 95 | |||
| age_at_collection_days | 95 | 100% | 95 | |||
| detailed_location | 95 | 100% | ||||
| health_condition_detail | 95 | 100% | 95 | |||
| intervention | 95 | 100% | 95 | |||
| intervention_detail | 95 | 100% | 95 | |||
| latitude | 95 | 100% | 95 | |||
| location_locality | 95 | 100% | 95 | |||
| location_region | 95 | 100% | 95 | |||
| longitude | 95 | 100% | 95 | |||
| sex | 95 | 100% | 95 | |||
| timepoint_label | 95 | 100% | 95 |
- Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. 2023 PMID 37910603 PMC10821315 unsure
- Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation. 2025 PMID 40542451 PMC12180181 unsure
Archive description
Randomized clinical trial of fecal microbiota transplant (FMT) for eradication of intestinal multi-drug resistant organism (MDRO) colonization after infection.
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of adult and elderly by deterministic_prior with confidence 0.90. Assay shotgun_dna.
- host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- body site study.description · “clinical trial of fecal microbiota transplant (FMT)”
- body site external_curation.infant_catalog · “body_site_call stool”
- life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- life stage sample.attr.host_age · “74 (n=44/95)”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMN19760871 | age_at_collection_days | 22280.2 | R1 | 0.70 | sample.attr.host_age | 61 |
| SAMN19760871 | country | US | R1 | 0.90 | sample.attr.geo_loc_name | USA: Atlanta, GA |
| SAMN19760871 | health_condition | type2_diabetes | R1 | 0.90 | biosample_attr | Diabetes |
| SAMN19760871 | health_condition_detail | mdro: yes | R1 | 0.85 | sample.attr.mdro_status | Positive |
| SAMN19760871 | intervention | fmt | R1 | 0.90 | biosample.attribute:Group | Group: FMT |
| SAMN19760875 | intervention | no_intervention | R1 | 0.80 | biosample.attribute:Visit | Visit: S1 |
| SAMN19760871 | intervention_detail | FMT treatment arm | R1 | 0.90 | biosample.attribute:Group | Group: FMT |
| SAMN19760875 | intervention_detail | screening visit before randomisation | R1 | 0.80 | biosample.attribute:Visit | Visit: S1 |
| SAMN19760871 | latitude | 33.7900 | R1 | 0.90 | biosample.attribute:lat_lon | 33.79 N 84.32 W |
| SAMN19760871 | location_locality | Atlanta | R1 | 0.85 | biosample.attribute:geo_loc_name | USA: Atlanta, GA |
| SAMN19760871 | location_region | Georgia | R1 | 0.75 | biosample.attribute:geo_loc_name | USA: Atlanta, GA |
| SAMN19760871 | longitude | -84.3200 | R1 | 0.90 | biosample.attribute:lat_lon | 33.79 N 84.32 W |
| SAMN19760871 | sex | female | R1 | 0.90 | sample.attr.host_sex | female |
| SAMN19760871 | subject_id | PM01 | R1 | 0.85 | sample.attr.host_subject_id | PM01 |
| SAMN19760871 | timepoint_label | C1D01 | R1 | 0.85 | sample.attr.visit | C1D01 |
Sequencing
155 runs over 95 samples · mean 2.46 Gbp per run (median 2.77 Gbp, total 381.37 Gbp; 155 runs with a base count) · layout PAIRED 155 · platform ILLUMINA 155 · models Illumina NovaSeq 6000 (82), NextSeq 550 (45), Illumina MiSeq (28) · 91% of runs with a Sandpiper profile · first public 2022-07-06
Authors (35)
Woodworth MH first · Conrad RE · Haldopoulos M · Pouch SM · Babiker A · Mehta AK · Sitchenko KL · Wang CH · Strudwick A · Ingersoll JM · Philippe C · Lohsen S · Kocaman K · Lindner BG · Hatt JK · Jones RM · Miller C · Neish AS · Friedman-Moraco R · Karadkhele G · Liu KH · Jones DP · Mehta CC · Ziegler TR · Weiss DS · Larsen CP · Konstantinidis KT · Kraft CS last · Ji S first · Ahmad F · Peng B · Yang Y · Su M · Zhao X · Vatanen T last
Downloads
PRJNA728680.csv.gz (3.7 KB) · parquet (75.1 KB) — all 95 samples, every field with route and confidence · PRJNA728680_determinations.csv.gz (8.8 KB) — 1,229 evidence rows